Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouTwo different assets get bundled into one clause in most GCC skincare agreements: an exclusive formula and exclusive packaging. They behave nothing alike commercially, regulatorily, or operationally — and treating them as one line…
Two different assets get bundled into one clause in most GCC skincare agreements: an exclusive formula and exclusive packaging. They behave nothing alike commercially, regulatorily, or operationally — and treating them as one line item is one of the most common reasons a Gulf launch slips a quarter or ends in a renegotiation. A formula carries registration consequences in each country where you file, lives inside a versioned specification, and is only defensible if the tested sample matches the commercial batch. Packaging carries tooling ownership, decoration plates, a validated combination ID, and a climate-and-transit engineering problem that has nothing to do with the formula’s exclusivity. This guide sets out how to separate the two in the brand agreement so that sourcing, regulatory filing, and quality each get a clean scope to work against. Informational only, not legal advice.
Exclusivity is only useful if it is enforceable and operationally real. A formula exclusive to your brand but filled into a stock bottle sold to three competitors is a half-exclusive product. A custom mould exclusive to your brand but paired with a formula your manufacturer may supply to anyone is equally weak. The agreement has to state, separately, what is owned, what is licensed, who may use it, in which countries, for how long, and against what volume.
| Dimension | Exclusive formula | Exclusive packaging |
|---|---|---|
| What is actually owned | Formula ID and frozen version; the developed know-how as defined in the contract; the technical dossier | Tooling/mould, decoration artwork and plates, supplier part numbers within a Combination ID |
| Main cost driver | Development, stability and compatibility testing, efficacy and consumer studies, dossier preparation | Mould amortisation, decoration tooling, MOQ per component, Golden Packaging samples |
| Typical lead time | Longer if efficacy or consumer claims are involved; stability and micro run in parallel with filling trials | Longer if new mould or new decoration is required; stock components still need validation against your formula |
| Market dependency | Must be defined per country: Saudi notification versus UAE (Dubai Municipality / Montaji) versus other GCC states | Defined by physical conditions: high heat, humidity, transit, retail storage, gifting/coffret packing |
| Impact of a change | May trigger re-testing, label changes, and re-filing in each market | May trigger re-validation of seal, dose, spray, and transport performance |
| Reference document | Approved Specification: identity, physical/chemical, micro, functional, net content, method IDs, acceptance criteria, change control | Combination ID record: bottle, pump/sprayer, cap/collar, gasket/dip tube, decoration, formula ID, validation index, Golden Packaging |
| How exclusivity is usually priced | Development fee plus volume-based or term-based exclusivity | Tooling fee plus minimum order quantity per component or per SKU |
| Failure mode if bundled | Exclusivity lapses silently when the formula is revised without notice | Exclusivity is claimed over a component the factory did not actually reserve |
The Gulf is not one market. Regulatory route, import process, channel structure, price architecture, and consumer usage all differ — Saudi Arabia and the UAE are the clearest example. A clause that grants exclusivity for “GCC” without a country list is unenforceable in practice and invites later disputes about whether a shipment to a neighbouring state breached it. Write the territory as a list of named countries and state explicitly whether “GCC” in the contract means all six member states or only those listed.
Avoid the phrase “worldwide compliant” entirely. Every statement in the agreement and in the marketing pack should be traceable to a named country and a named document.
Exclusivity over an undefined formula is a promise without an object. The agreement should reference a specific Formula ID and version, and state that the approved specification is the controlling document — including Method IDs and acceptance criteria — and that any modification requires version control and written approval. If development continues after efficacy testing, an impact assessment should be mandatory whenever fragrance, preservative, key actives, or process change. For higher-risk claims, substituting a “close enough” formula for the registered or commercial formula is not acceptable.
In the UAE, the local licensed importer, distributor, or registration holder is the responsible party for notification and permits, and for final label approval including Arabic content. The manufacturer’s role is to supply the dossier: formula, fragrance documentation, COA/SDS, free-sale or manufacturing qualification, label file, stability and compatibility reports, and samples. The agreement should separate these obligations clause by clause, because a gap here is the most common cause of a product sitting in a warehouse with no valid registration.
A packaging combination is only usable once it has been validated with your specific formula, filling process, transport conditions, and consumer use. Lock the exclusivity to a unique combination reference that includes the bottle supplier, mould or part number, material, colour and version; the pump or sprayer supplier, model, dose and version; the cap/collar; the gasket and dip tube material, length and version; the decoration specification and approved sample; the Formula ID; the validation record index; and the signed Golden Packaging sample with drawings, photos, and limit samples.
Three distinct assets are usually in play: the mould or tooling, the decoration artwork and plates, and the approved Golden Packaging sample archive. State who owns each, who may use it after termination, whether it can be transferred to another filler, and what the handover cost is. Volume commitments should be tied to the packaging line item separately from the formula line item, so that a shortfall in one does not silently void exclusivity in the other.
GCC skincare programmes put disproportionate stress on sealing, actuation, decoration durability, and secondary packaging. Heat exposure in transit and storage, humidity, and gift-set configurations all need to be reflected in the validation plan — compatibility, leakage, transport, dispensing function, and high-temperature stability. These are packaging obligations, not formula obligations, and the agreement should say so.
| Request | Evidence that proves it | Owner |
|---|---|---|
| Definition of the exclusive formula | Approved Specification with Formula ID, version, Method IDs, acceptance criteria, and change-control section | Manufacturer |
| Definition of the exclusive pack | Combination ID record covering bottle, pump/sprayer, cap, gasket/dip tube, decoration, Formula ID, validation index | Manufacturer plus packaging suppliers |
| Proof the pack works with this formula | Compatibility, leakage, transport, dispensing-function and high-temperature test reports linked to the same Combination ID | Manufacturer / Lab |
| Registration-ready dossier | Formula, fragrance documentation, COA/SDS, free-sale or manufacturing qualification, label file, stability and micro reports, samples | Manufacturer supplies; Buyer or importer files |
| Claim support for the launch copy | Frozen protocol with test ID, formula and packaging versions, endpoints, acceptance criteria, and final report | Lab / Manufacturer |
| Signed physical reference | Golden Packaging sample with drawings, specification, photographs and limit-sample archive | Manufacturer plus Packaging supplier |
| Phase | Buyer action | Manufacturer action | Evidence output |
|---|---|---|---|
| Scope lock | Confirm launch country list, SKUs, channel, and claim set | Confirm which formula versions and which Combination IDs are being reserved | Signed scope annex with country list and IDs |
| Packaging lock | Approve components and decoration direction | Issue Combination ID, order tooling and components, issue drawings | Combination ID record plus approved artwork |
| Validation | Approve test plan and claim list | Run compatibility, leakage, transport, high-temperature and stability work | Test reports indexed to the Combination ID and Formula ID |
| Label and claims review | Confirm Arabic/bilingual label content and claim wording with the local registration holder | Supply INCI, allergen information, warnings and supporting documents | Approved label file and claim substantiation pack |
| Pilot and handover | Approve Golden Packaging and first production batch | Run pilot, release batch, hand over dossier | Golden Packaging archive, COA, batch record, final technical file |
A compressed path is possible when the formula already exists and only decoration is new, or when stock components are validated early against the final formula. What cannot be compressed is the validation step itself, and what cannot be skipped is re-testing after a formula change.
It can be drafted that way, but it usually fails in practice. The two assets have different owners, different cost drivers, different validation evidence, and different change triggers. Separating them makes it possible to define volume conditions, termination handover, and evidence for each independently.
No. Dubai registration through the applicable systems does not automatically cover the other emirates or other GCC countries. Each target market has its own notification route, labelling requirements, and restricted-ingredient checks, and the local licensed importer or registration holder is normally the responsible party for filing.
Fragrance can interact with plastic components, gaskets, and decoration, so a fragrance change should trigger a compatibility review rather than an automatic pass. It also requires an impact assessment on the formula side, because a change to the fragrance is a change to the tested sample.
Only if the agreement says so and the combination has been reserved. Decoration artwork can be exclusive while the bottle itself remains a catalogue item available to other brands. State clearly which layer — mould, component, decoration, or assembled combination — is exclusive to you.
A signed annex listing the Formula ID and version, the Combination ID with all component part numbers, the named territories, the volume conditions, and the Golden Packaging reference. Everything else — the specification, the test reports, the label file — hangs off those identifiers.
If you are preparing a GCC skincare launch and need the formula and packaging scopes documented separately before you sign, send your target countries, SKU list and formats, positioning, packaging direction, and timeline. That information is what allows a quotation and a scope annex to be issued without a round of clarification. Request a Quote